Home / Stocks / DPL
Back to all stocks
BSE · DPL

DIPNA PHARMACHEM LIMITED (DPL) Share Price

Sector: Healthcare · ISIN: INE0MC401013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,506
of 5,047 stocks
▼ 261W▲ 191M
Peak #4,414 · 21 Sep 2026

A microcap name in Healthcare, DIPNA PHARMACHEM LIMITED trades at an undemanding earnings multiple, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 9%. Ownership as of Jun 2026.

Market Cap
11.09 Cr
P/E Ratio
4.22
P/B Ratio
0.18
ROE
4.22%
ROCE
6.92%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q4 2025-26Q4 2024-25
Revenue20.33 Cr2.02 Cr15.92 Cr
Net Profit39.42 L17.86 L50.13 L
EPS0.150.070.21
Operating Profit82.96 L45.42 L1.28 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
9.13%
Public
90.87%

PUBLIC BREAKDOWN

Individuals
84.16%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
12 Feb 2024OtherRight Issue of Equity Shares

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs